• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
HTGM

HTGM

HTG Molecular Diagnostics, Inc.

NASDAQHealthcareMedical - Diagnostics & ResearchUS

USD0.48

+0.00 (+0.00%)

Company Profile

CEO

John L. Lubniewski

IPO Date

2015-05-06

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.57

Prev. Close

$0.48

Day Low

$0.48

Day High

$0.48

52W Low

$0.46

52W High

$24.96

Market Cap

$0.00B

Volume

0.73M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

23.7%

Avg Negative

3.8%

Avg Neutral

72.4%

News Feed

HTG Molecular Diagnostics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewsWire·7/23/2021·↑ positive

HTGM Stock Price: 7.34% Increase Explanation

Pulse2·5/26/2021·↑ positive

HTG EdgeSeq Technology Highlighted in Several Posters Being Presented at the American Society of Clinical Oncology 2021 Virtual Conference

GlobeNewsWire
·5/24/2021
·↑ positive

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/13/2021·↓ negative

HTG Molecular Diagnostics to Announce Q1 2021 Financial Results and Host Conference Call on Thursday, May 13

GlobeNewsWire·5/4/2021·↓ negative

HTG Molecular Diagnostics Reports Preliminary First Quarter 2021 Financial Results

GlobeNewsWire·4/5/2021·↓ negative

HTG Molecular Diagnostics, Inc. (HTGM) CEO John Lubniewski on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/25/2021·↓ negative

HTG Molecular Diagnostics to Announce Year End 2020 Financial Results and Host Conference Call on Thursday, March 25

GlobeNewsWire·3/16/2021·↑ positive

3 Cancer Diagnostic Stocks To Watch Following Roche's GenMark Buy

Benzinga·3/16/2021·↑ positive

HTG Concludes Feasibility Testing & Releases Second White Paper for its Planned Whole Transcriptome Panel Using HTG EdgeSeq Technology

GlobeNewsWire·2/26/2021·↑ positive